(Q46452876)

22 December 2017

title

Safety assessment of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable renal transplant recipients (English)

1 reference

22 December 2017

author name string

P Massari

1

1 reference

22 December 2017

V Duro-Garcia

2

1 reference

22 December 2017

F Girón

3

1 reference

22 December 2017

E Hernández

4

1 reference

22 December 2017

F Juárez

5

1 reference

22 December 2017

C Castro

6

1 reference

22 December 2017

M Toledo

7

1 reference

22 December 2017

myPROMS LatAm Study Group

8

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

22 December 2017

Transplantation Proceedings

published in

1 reference

22 December 2017

volume

37

1 reference

22 December 2017

issue

2

1 reference

22 December 2017

page(s)

916-919

1 reference

22 December 2017

Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.020

Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.020

Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.020

The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.020

Enteric-coated mycophenolate sodium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.020

Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.020

Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.020

Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant patients: preliminary results from the myfortic prospective multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.020

Stable renal transplant recipients can be safely converted from MMF to enteric-coated mycophenolate sodium tablets: Interim results of a multicenter Latin American study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.020

10.1016/J.TRANSPROCEED.2004.12.020

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017